Becton Dickinson (BDX) Shares Outstanding (Weighted Average) (2009 - 2026)
Becton Dickinson (BDX) reported Shares Outstanding (Weighted Average) of $283.1 million for Q1 2026, down 1.83% year-over-year from $288.4 million in Q1 2025, and down 0.86% quarter-over-quarter from $285.6 million in Q4 2025.
Becton Dickinson (BDX) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $283.1 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $283.1 million, down 1.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $283.1 million (down 1.83% YoY), and the FY2025 annual result was $287.6 million, down 0.73% from the prior year.
- Shares Outstanding (Weighted Average) retreated to $283.1 million in Q1 2026 per BDX's latest filing, from $285.6 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $290.1 million in Q4 2023 and troughed at $283.1 million in Q1 2026.
- A 5-year average of $286.9 million and a median of $286.3 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) slipped 1.92% in 2022, then increased 2.19% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $283.9 million in 2022, then climbed by 2.19% to $290.1 million in 2023, then dropped by 0.21% to $289.5 million in 2024, then fell by 1.36% to $285.6 million in 2025, then slipped by 0.86% to $283.1 million in 2026.
- Business Quant data shows BDX's Shares Outstanding (Weighted Average) at $283.1 million in Q1 2026, $285.6 million in Q4 2025, and $287.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 64.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 283.14 Mn |
| Dec 31, 2025 | 285.58 Mn |
| Sep 30, 2025 | 287.65 Mn |
| Jun 30, 2025 | 288.00 Mn |
| Mar 31, 2025 | 288.41 Mn |
| Dec 31, 2024 | 289.51 Mn |
| Sep 30, 2024 | 289.76 Mn |
| Jun 30, 2024 | 289.56 Mn |
| Mar 31, 2024 | 289.94 Mn |
| Dec 31, 2023 | 290.11 Mn |
| Sep 30, 2023 | 286.28 Mn |
| Jun 30, 2023 | 286.32 Mn |
| Mar 31, 2023 | 284.29 Mn |
| Dec 31, 2022 | 283.89 Mn |
| Sep 30, 2022 | 285.01 Mn |
| Jun 30, 2022 | 285.44 Mn |
| Mar 31, 2022 | 285.24 Mn |
| Dec 31, 2021 | 284.69 Mn |
| Sep 30, 2021 | 289.29 Mn |
| Jun 30, 2021 | 290.40 Mn |